Financial Daily from THE HINDU group of publications
Saturday, Jan 26, 2002
Financial Daily from THE HINDU group of publications Saturday, Jan 26, 2002 |
|
|
|
|
|
Corporate Results
-
Pharmaceuticals Neuland Labs net, turnover up in Q3 Our Bureau
Our Bureau NEW DELHI, Jan. 25 NEULAND Laboratories Ltd (NLL) has registered a growth in turnover and net profit for the third quarter of current fiscal year ended December 31, 2001. While sales from operations were up at Rs 25.35 crore from Rs 22.37 crore in the corresponding quarter last fiscal, the other income was up at Rs 47.65 lakh (Rs 3.51 lakh) and net profit increased to Rs 1.07 crore (Rs 97.14 lakh) on an equity of Rs 5.38 crore, yielding an EPS of Rs 1.86 (Rs 1.58). For the quarter under review, the company incurred an expenditure of Rs 22.13 crore (Rs 19.36 crore) and provided Rs 1.73 crore towards interest and other charges (Rs 1.48 crore), Rs 80.81 lakh towards depreciation (Rs 59.7 lakh) and Rs 8.5 lakh towards taxation as against no such provision in the corresponding quarter. For the nine months period ended December 31, 2001, NLL achieved a turnover of Rs 75.92 crore (Rs 63.14 crore) and a net profit of Rs 3.19 crore (Rs 2.83 crore), yielding an EPS of Rs 5.53 (Rs 4.6).
Send this article to Friends by E-Mail
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|